Summit Global Investments Blueprint Medicines Corp Transaction History

Summit Global Investments

  • $1.57 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 23, 2022
SELL
$45.23 - $70.15 $840,463 - $1.3 Million
-18,582 Closed
0 $0
Q1 2022

Apr 29, 2022
SELL
$54.1 - $110.08 $525,419 - $1.07 Million
-9,712 Reduced 34.33%
18,582 $1.19 Million
Q4 2021

Feb 14, 2022
BUY
$94.25 - $115.99 $396,038 - $487,389
4,202 Added 17.44%
28,294 $3.03 Million
Q3 2021

Nov 08, 2021
BUY
$80.98 - $109.47 $1.95 Million - $2.64 Million
24,092 New
24,092 $2.48 Million

Others Institutions Holding BPMC

# of Institutions
351
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Summit Global Investments Portfolio

Follow Summit Global Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email